TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260409. A total of 23 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $11,000 | – | 2,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| B. Riley Financial, Inc. | 281,626 | $1,284,000 | 0.35% |
| Nine Chapters Capital Management LLC | 19,600 | $89,000 | 0.20% |
| Baker Brothers Advisors | 699,500 | $3,190,000 | 0.03% |
| A.R.T. Advisors, LLC | 42,092 | $191,000 | 0.01% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 8,800 | $40,000 | 0.00% |
| Virtu Financial LLC | 12,320 | $56,000 | 0.00% |
| OPPENHEIMER & CO INC | 13,500 | $62,000 | 0.00% |
| GLENMEDE TRUST CO NA | 100 | $0 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 20,121 | $92,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 400 | $2,000 | 0.00% |